New Covid Cases And Its Impacts On The Economy
Indian pharma is being squeezed – and it's bad news for drug access in developing countries
Moderna banks $1.1bn in COVID-19 vaccine deposits, signs Japan supply deal
Futures Rebound From Overnight Tech Wreck
What you should and SHOULDN’T be spending money on during the pandemic
Three ways to head off the next pandemic in the wild meat trade
Stocks Struggle To Stabilize After Worst Rout Since June
Mastercard Dips 8% As 3Q Profit Disappoints; Street Sticks To Buy
Euro Falls Against Dollar as EU Countries Initiate 2nd Lockdown
Europe On The Cusp Of New Lockdowns As Brussels Plots Pan-EU Restrictions: Live Updates
Low carbon ETFs to drive ESG growth in Europe
Futures Rebound From Monday's Plunge On Strong Earnings, Mega Merger
Markets Take Collective Breath and Beijing Tweaks Fixing Mechanism
Is Aphria A Better Cannabis Bet Than Canopy Growth?
Morgan Stanley Models The Number Of Covid Infections In 2021: Here Are The Bull, Bear And Base Cases
Futures Tumble, European Tech Stocks Plunge Amid Surging Virus Cases, Reflation Trade Fears
PhaseBio Plunges 10% As Covid-19 Trial Called Off; Street Stays Bullish
AstraZeneca Says Its COVID-19 Vaccine Produces Robust Immune Response In Elderly Patients
Weekly Market Outlook: BOC, BOJ, ECB and corporate earnings in focus
AstraZeneca Gets FDA Nod To Resume US Covid-19 Trial
The Destruction Of The Euro
Double-Dip Recession Imminent (Or Did The First One Ever End?)
Week Ahead – The final stretch
Global Markets Rise Despite Fading Odds Of Stimulus Deal
Gilead’s Covid-19 Remdesivir Drug Scores FDA Approval; Shares Surge
Russophrenia... Or How A Collapsing Country Runs The World
A Tale of 2 Automotive Stocks to Buy
COVID-19 Records Shattered Across Europe As France Tops 40k New Cases: Live Updates
Central Europe Reports Record Jump In COVID-19 Cases; US Hospitalizations Hit 2-Month High: Live Updates
American Airlines Posts $2.4B Quarterly Loss; Street Sees 22% Downside